Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha‐Fetoprotein–Negative Patients With Cirrhotic Nodules

Abstract

By enabling diagnosis months earlier than conventional methods, ctDNA-based testing may enhance HCC surveillance and facilitate a more personalized approach to cancer monitoring.